Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis-Reference-Cited by-同舟云学术

Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis

Published:2022-03-26 Issue:10 Volume:28 Page:1614-1617
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Gandhi Shiv¹,Zelman Sara¹,De Armas Ricardo Eduardo²,Hemond Christopher³,Levy Alexander N¹,Singh Siddharth⁴,Korzenik Joshua²,Jangi Sushrut¹^ORCID

Affiliation:

1. Division of Gastroenterology, Tufts Medical Center , Boston, MA , United States

2. Division of Gastroenterology, Brigham and Women’s Hospital , Boston, MA , United States

3. Division of Neurology, University of Massachusetts Medical School , Worcester, MA , United States

4. Division of Gastroenterology, University of California , La Jolla, CA , United States

Abstract

Lay Summary Patients with MS and IBD were as likely to have stricturing, fistulizing, and extensive IBD as IBD controls. Although MS-IBD patients were less likely to initiate anti-TNF therapy, they did not have worsened risk of progression to surgery on follow-up.

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izac053/43057061/izac053.pdf

Reference8 articles.

1. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials;Schreiber;Ann Rheum Dis.,2019

2. New IBD genetics: common pathways with other diseases;Lees;Gut.,2011

3. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn’s disease;Thomas;Inflamm Bowel Dis.,2004

4. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics;Singh;Inflamm Bowel Dis.,2013

5. The comeback kid: TYSABRI now FDA approved for Crohn disease.;Honey;J Clin Invest.,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Bowel Disease and Neurodegenerative Diseases;Gut and Liver;2023-02-27